Akèy › Skleroz an milti pwogresif kwonik › Tennessee › Memphis
Etid klinik pou Skleroz an milti pwogresif kwonik nan Memphis, TN
4 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Neurology Clinic, P.C., Cordova · 15 mi lwen
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Ap rekriteFaz 4
- Neurology Clinic PC, Cordova · 15 mi lwen
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Neurology Clinic, P.C., Cordova · 15 mi lwen
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Neurology Clinic PC, Cordova · 15 mi lwen
Etid Skleroz an milti pwogresif kwonik nan lòt vil
- Chicago, IL4 etid
- St. Louis, MO4 etid
- Orlando, FL4 etid
- Kansas City, KS3 etid
- Columbus, OH3 etid
- Greenville, SC3 etid
- Tampa, FL3 etid
- Burbank, CA3 etid
- Scottsdale, AZ3 etid
Lòt etid nan Memphis
- Kansè (tout kalite)31 etid
- Kansè Poumon ki pa ti selil23 etid
- Kansè nan tete22 etid
- Kansè poumon18 etid
- Maladi selil fòs18 etid
- Leksemi limfoblastik egi16 etid
- Leksemi mieloïd egi15 etid
- Ensifizyans kadyak13 etid
- Kansè kolorektal11 etid
- Sarkom tisi mou11 etid
- Melanom11 etid
- Kansè pwostat11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.